Depression and anxiety both associate with serum level of hs-CRP: A gender-stratified analysis in a population-based study

Psychoneuroendocrinology

Volumn 81, Issue , 2017, Pages 63-69

  Tayefi, Maryam ^a   Shafiee, Mojtaba ^a   Kazemi Bajestani, Seyyed Mohammad Reza ^a,b,c   Esmaeili, Habibolah ^d   Darroudi, Susan ^a   Khakpouri, Samaneh ^a   Mohammadi, Maryam ^a   Ghaneifar, Zahra ^a   Azarpajouh, Mahmoud Reza ^b   Moohebati, Mohsen ^b   Heidari Bakavoli, Alireza ^b   Parizadeh, Mohammad Reza ^a   Nematy, Mohsen ^a   Safarian, Mohammad ^a   Ebrahimi, Mahmoud ^b   Ferns, Gordon A ^e   Mokhber, Naghmeh ^a,b   Ghayour Mobarhan, Majid ^a  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c UNIVERSITY OF ALBERTA   (Canada)

^d MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e BRIGHTON AND SUSSEX MEDICAL SCHOOL   (United Kingdom)

Author keywords

Anxiety; Depression; High sensitivity C reactive protein; Inflammation; Obesity; Smoking

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGE DISTRIBUTION; AGED; ANXIETY DISORDER; ARTICLE; BECK ANXIETY INVENTORY; BECK DEPRESSION INVENTORY; COHORT ANALYSIS; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; HUMAN; INFLAMMATION; IRAN; IRANIAN PEOPLE; MAJOR CLINICAL STUDY; MALE; OBESITY; POPULATION RESEARCH; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; SEX DIFFERENCE; SMOKING HABIT; SYMPTOM; ANXIETY; CASE CONTROL STUDY; METABOLISM; MIDDLE AGED; RISK FACTOR; SEX FACTOR;

ADULT; AGED; ANXIETY; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; COHORT STUDIES; DEPRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; SEX FACTORS;

EID: 85017459827     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2017.02.035     Document Type: Article

References (63)

1. Abu-Taha, M., Rius, C., Hermenegildo, C., Noguera, I., Cerda-Nicolas, J.M., Issekutz, A.C., Jose, P.J., Cortijo, J., Morcillo, E.J., Sanz, M.J., Menopause and ovariectomy cause a low grade of systemic inflammation that may be prevented by chronic treatment with low doses of estrogen or losartan. J. Immunol. (Baltimore, Md.: 1950) 183 (2009), 1393–1402.
2. Anda, R.F., Williamson, D.F., Escobedo, L.G., Mast, E.E., Giovino, G.A., Remington, P.L., Depression and the dynamics of smoking: a national perspective. JAMA 264 (1990), 1541–1545.
3. Anda, R., Williamson, D., Jones, D., Macera, C., Eaker, E., Glassman, A., Marks, J., Depressed affect, hopelessness, and the risk of ischemic heart disease in a cohort of US adults. Epidemiology 4 (1993), 285–294.
4. Annique, S., Dorien, T., Richel, L., Gunter, K., Joris, D., Harry, J.C., Gert, G., Frank, S., Michael, M., Adriaan, H., Inflammatory markers in depressed post-myocardial infarction patients. J. Psychiatr. Res. 39 (2005), 137–144.
5. Bankier, B., Barajas, J., Martinez-Rumayor, A., Januzzi, J.L., Association between C-reactive protein and generalized anxiety disorder in stable coronary heart disease patients. Eur. Heart J. 29 (2008), 2212–2217.
6. Baune, B., Smith, E., Reppermund, S., Air, T., Samaras, K., Lux, O., Brodaty, H., Sachdev, P., Trollor, J., Inflammatory biomarkers predict depressive, but not anxiety symptoms during aging: the prospective Sydney Memory and Aging Study. Psychoneuroendocrinology 37 (2012), 1521–1530.
7. Beck, A.T., Epstein, N., Brown, G., Steer, R.A., An inventory for measuring clinical anxiety: psychometric properties. J. Consult. Clin. Psychol., 56, 1988, 893.
8. Boden, J.M., Fergusson, D.M., Horwood, L.J., Cigarette smoking and depression: tests of causal linkages using a longitudinal birth cohort. B. J. Psychiatry 196 (2010), 440–446.
9. Bremmer, M., Beekman, A., Deeg, D., Penninx, B., Dik, M., Hack, C., Hoogendijk, W., Inflammatory markers in late-life depression: results from a population-based study. J. Affect. Disord. 106 (2008), 249–255.
10. Breslau, N., Peterson, E.L., Schultz, L.R., Chilcoat, H.D., Andreski, P., Major depression and stages of smoking: a longitudinal investigation. Arch. Gen. Psychiatry 55 (1998), 161–166.
11. Brown, R.A., Lewinsohn, P.M., Seeley, J.R., Wagner, E.F., Cigarette smoking, major depression, and other psychiatric disorders among adolescents. J. Am. Acad. Child Adolesc. Psychiatry 35 (1996), 1602–1610.
12. Brown, C., Madden, P.A., Palenchar, D.R., Cooper-Patrick, L., The association between depressive symptoms and cigarette smoking in an urban primary care sample. Int. J. Psychiatry Med. 30 (2000), 15–26.
13. Camacho, Á., Larsen, B., McClelland, R.L., Morgan, C., Criqui, M.H., Cushman, M., Allison, M.A., Association of subsyndromal and depressive symptoms with inflammatory markers among different ethnic groups: the multi-ethnic study of atherosclerosis (MESA). J. Affect. Disord. 164 (2014), 165–170.
14. Chocano-Bedoya, P.O., Mirzaei, F., O'Reilly, E.J., Lucas, M., Okereke, O.I., Hu, F.B., Rimm, E.B., Ascherio, A., C-reactive protein, interleukin-6, soluble tumor necrosis factor α receptor 2 and incident clinical depression. J. Affect. Disord. 163 (2014), 25–32.
15. Choi, W.S., Patten, C.A., Gillin, J.C., Kaplan, R.M., Pierce, J.P., Cigarette smoking predicts development of depressive symptoms among U.S. adolescents. Ann. Behav. Med. 19 (1997), 42–50.
16. Collins, B.N., Lepore, S.J., Association between anxiety and smoking in a sample of urban black men. J. Immigr. Minor. Health 11 (2009), 29–34.
17. Danner, M., Kasl, S.V., Abramson, J.L., Vaccarino, V., Association between depression and elevated C-reactive protein. Psychosom. Med. 65 (2003), 347–356.
18. Davidson, K.W., Schwartz, J.E., Kirkland, S.A., Mostofsky, E., Fink, D., Guernsey, D., Shimbo, D., Relation of inflammation to depression and incident coronary heart disease (from the canadian nova scotia health survey [NSHS95] prospective population study). Am. J. Cardiol. 103 (2009), 755–761.
19. Dixon, J.B., Dixon, M.E., O'Brien, P.E., Depression in association with severe obesity: changes with weight loss. Arch. Intern. Med. 163 (2003), 2058–2065.
20. Dozois, D.J., Dobson, K.S., Ahnberg, J.L., A psychometric evaluation of the beck depression Inventory–II. Psychol. Assess., 10, 1998, 83.
21. Duivis, H.E., Vogelzangs, N., Kupper, N., de Jonge, P., Penninx, B.W., Differential association of somatic and cognitive symptoms of depression and anxiety with inflammation: findings from the Netherlands Study of Depression and Anxiety (NESDA). Psychoneuroendocrinology 38 (2013), 1573–1585.
22. Elovainio, M., Keltikangas-Järvinen, L., Pulkki-Råback, L., Kivimäki, M., Puttonen, S., Viikari, L., Räsänen, L., Mansikkaniemi, K., Viikari, J.T., Raitakari, O., Depressive symptoms and C-reactive protein: the cardiovascular risk in young finns study. Psychol. Med. 36 (2006), 797–805.
23. Elovainio, M., Aalto, A.-M., Kivimäki, M., Pirkola, S., Sundvall, J., Lönnqvist, J., Reunanen, A., Depression and C-reactive protein: population-based health 2000 study. Psychosom. Med. 71 (2009), 423–430.
24. Emamian, M., Hasanian, S.M., Tayefi, M., Bijari, M., Movahedian Far, F., Shafiee, M., Avan, A., Heidari-Bakavoli, A., Moohebati, M., Ebrahimi, M., Darroudi, S., Zamani, P., Azarpazhooh, M.R., Nematy, M., Safarian, M., Ferns, G.A., Esmaeili, H., Parizadeh, M.R., Ghayour-Mobarhan, M., Association of hematocrit with blood pressure and hypertension. J. Clin. Lab. Anal., 2017.
25. Escobedo, L.G., Reddy, M., Giovino, G.A., T he relationship between and cigarette sm oking in depressive sym ptom s US adolescents. Addiction 93 (1998), 433–440.
26. Fergusson, D.M., Goodwin, R.D., Horwood, L.J., Major depression and cigarette smoking: results of a 21-year longitudinal study. Psychol. Med. 33 (2003), 1357–1367.
27. Ferketich, A.K., Schwartzbaum, J.A., Frid, D.J., Moeschberger, M.L., Depression as an antecedent to heart disease among women and men in the NHANES I study. Arch. Intern. Med. 160 (2000), 1261–1268.
28. Ford, D.E., Erlinger, T.P., Depression and C-reactive protein in US adults: data from the third national health and nutrition examination survey. Arch. Intern. Med. 164 (2004), 1010–1014.
29. Ford, D.E., Mead, L.A., Chang, P.P., Cooper-Patrick, L., Wang, N.Y., Klag, M.J., Depression is a risk factor for coronary artery disease in men: the precursors study. Arch. Intern. Med. 158 (1998), 1422–1426.
30. Gariepy, G., Nitka, D., Schmitz, N., 2010: The association between obesity and anxiety disorders in the population: a systematic review and meta-analysis. Int. J. Obes. 34:2005 (2010), 407–419.
31. Ghassemzadeh, H., Mojtabai, R., Karamghadiri, N., Ebrahimkhani, N., Psychometric properties of a Persian-language version of the Beck Depression Inventory-Second edition: BDI-II-PERSIAN. Depress. Anxiety 21 (2005), 185–192.
32. Ghayour-Mobarhan, M., Moohebati, M., Esmaily, H., Ebrahimi, M., Parizadeh, S.M.R., Heidari-Bakavoli, A.R., Safarian, M., Mokhber, N., Nematy, M., Saber, H., Mashhad stroke and heart atherosclerotic disorder (MASHAD) study: design, baseline characteristics and 10-year cardiovascular risk estimation. Int. J. Public Health 60 (2015), 561–572.
33. Gimeno, D., Kivimäki, M., Brunner, E.J., Elovainio, M., De Vogli, R., Steptoe, A., Kumari, M., Lowe, G.D., Rumley, A., Marmot, M.G., Associations of C-reactive protein and interleukin-6 with cognitive symptoms of depression: 12-year follow-up of the Whitehall II study. Psychol. Med. 39 (2009), 413–423.
34. Halder, I., Marsland, A.L., Cheong, J., Muldoon, M.F., Ferrell, R.E., Manuck, S.B., Polymorphisms in the CRP gene moderate an association between depressive symptoms and circulating levels of C-reactive protein. Brain Behav. Immun. 24 (2010), 160–167.
35. Johnson, J.G., Cohen, P., Pine, D.S., Klein, D.F., Kasen, S., Brook, J.S., Association between cigarette smoking and anxiety disorders during adolescence and early adulthood. JAMA 284 (2000), 2348–2351.
36. Jorm, A.F., Korten, A.E., Christensen, H., Jacomb, P.A., Rodgers, B., Parslow, R.A., Association of obesity with anxiety, depression and emotional well-being: a community survey. Aust. N. Z. J. Public Health 27 (2003), 434–440.
37. Kamphuis, M.H., Kalmijn, S., Tijhuis, M.A., Geerlings, M.I., Giampaoli, S., Nissinen, A., Grobbee, D.E., Kromhout, D., Depressive symptoms as risk factor of cardiovascular mortality in older European men: the Finland, Italy and Netherlands Elderly (FINE) study. Eur. J. Cardiovas. Prev. Rehab. 13 (2006), 199–206.
38. Kaviani, H., Mousavi, A., Psychometric properties of the persian version of beck anxiety inventory (BAI). Tehran Univ. Med. J. (TUMJ) 66 (2008), 136–140.
39. Kazemi-Bajestani, S.M.R., Ghayour-Mobarhan, M., Ebrahimi, M., Ebrahimi, M., Moohebati, M., Esmaeili, H., Ferns, G., C-reactive protein associated with coronary artery disease in Iranian patients with angiographically defined coronary artery disease. Clin. Lab., 53, 2007, 49.
40. Kazemi-Bajestani, S.M., Tayefi, M., Ebrahimi, M., Heidari-Bakavoli, A.R., Moohebati, M., Parizadeh, S.M., Esmaeili, H., Ferns, G.A., Ghayour-Mobarhan, M., The prevalence of metabolic syndrome increases with serum high sensitivity C-reactive protein concentration in individuals without a history of cardiovascular disease: a report from a large Persian cohort. Ann. Clin. Biochem., 4563216676842, 2017.
41. Keddie, A.M., Associations between severe obesity and depression: results from the National Health and Nutrition Examination Survey, 2005–2006. Prev. Chronic Dis., 8, 2011, A57.
42. Kendler, K.S., Neale, M.C., MacLean, C.J., Heath, A.C., Eaves, L.J., Kessler, R.C., Smoking and major depression: a causal analysis. Arch. Gen. Psychiatry 50 (1993), 36–43.
43. Koenig, W., Sund, M., Fröhlich, M., Fischer, H.-G., Löwel, H., Döring, A., Hutchinson, W.L., Pepys, M.B., C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984–1992. Circulation 99 (1999), 237–242.
44. Kuller, L.H., Tracy, R.P., Shaten, J., Meilahn, E.N., Group, M.R., Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Am. J. Epidemiol. 144 (1996), 537–547.
45. Liukkonen, T., Räsänen, P., Jokelainen, J., Leinonen, M., Järvelin, M.-R., Meyer-Rochow, V., Timonen, M., The association between anxiety and C-reactive protein (CRP) levels: results from the Northern Finland 1966 birth cohort study. Eur. Psychiatry 26 (2011), 363–369.
46. Ma, J., Xiao, L., Obesity and depression in US women: results from the 2005–2006 national health and nutritional examination survey. Obesity (Silver Spring, Md.) 18 (2010), 347–353.
47. Ma, Y., Chiriboga, D.E., Pagoto, S.L., Rosal, M.C., Li, W., Merriam, P.A., Hébert, J.R., Whited, M.C., Ockene, I.S., Association between depression and C-reactive protein. Cardiol. Res. Pract., 2011, 2010.
48. Mirhafez, S.R., Mohebati, M., Feiz Disfani, M., Saberi Karimian, M., Ebrahimi, M., Avan, A., Eslami, S., Pasdar, A., Rooki, H., Esmaeili, H., Ferns, G.A., Ghayour-Mobarhan, M., An imbalance in serum concentrations of inflammatory and anti-inflammatory cytokines in hypertension. J. Am. Soc. Hypertens.: JASH 8 (2014), 614–623.
49. Mitchell, J.E., Dahlgren, L.A., Prevalence of smoking among psychiatric outpatients. Am. J. Psychiatry 143 (1986), 993–997.
50. Morrell, H.E., Cohen, L.M., Cigarette smoking, anxiety, and depression. J. Psychopathol. Behav. Assess. 28 (2006), 281–295.
51. Morris, A., Zhao, L., Ahmed, Y., Stoyanova, N., Hooper, W.C., Gibbons, G., Din-Dzietham, R., Quyyumi, A., Vaccarino, V., Association between depression and inflammation–differences by race and sex: the META-Health study. Psychosom. Med., 73, 2011, 462.
52. Muntingh, A.D., van der Feltz-Cornelis, C.M., van Marwijk, H.W., Spinhoven, P., Penninx, B.W., van Balkom, A.J., Is the beck anxiety inventory a good tool to assess the severity of anxiety? A primary care study in The Netherlands study of depression and anxiety (NESDA). BMC Fam. Pract., 12, 2011, 66.
53. Palinkas, L.A., Wingard, D.L., Barrett-Connor, E., Depressive symptoms in overweight and obese older adults: a test of the jolly fat hypothesis. J. Psychosom. Res. 40 (1996), 59–66.
54. Ridker, P.M., Hennekens, C.H., Buring, J.E., Rifai, N., C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. New Engl. J. Med. 342 (2000), 836–843.
55. Scogin, F., Beutler, L., Corbishley, A., Hamblin, D., Reliability and validity of the short form Beck Depression Inventory with older adults. J. Clin. Psychol. 44 (1988), 853–857.
56. Stone, N.J., Bilek, S., Rosenbaum, S., Recent national cholesterol education program adult treatment panel III update: adjustments and options. Am. J. Cardiol. 96 (2005), 53e–59e.
57. Stunkard, A.J., Faith, M.S., Allison, K.C., Depression and obesity. Biol. Psychiatry 54 (2003), 330–337.
58. Surtees, P.G., Wainwright, N.W., Luben, R.N., Wareham, N.J., Bingham, S.A., Khaw, K.-T., Depression and ischemic heart disease mortality: evidence from the EPIC-Norfolk United Kingdom prospective cohort study. Am. J. Psychiatry 165 (2008), 515–523.
59. Van der Kooy, K., van Hout, H., Marwijk, H., Marten, H., Stehouwer, C., Beekman, A., Depression and the risk for cardiovascular diseases: systematic review and meta analysis. Int. J. Geriatr. Psychiatry 22 (2007), 613–626.
60. Vetter, M.L., Wadden, T.A., Vinnard, C., Moore, R.H., Khan, Z., Volger, S., Sarwer, D.B., Faulconbridge, L.F., Gender differences in the relationship between symptoms of depression and high-sensitivity CRP. Int. J. Obes. 37 (2013), S38–S43.
61. Vogelzangs, N., Beekman, A., De Jonge, P., Penninx, B., Anxiety disorders and inflammation in a large adult cohort. Transl. Psychiatry, 3, 2013, e249.
62. Whooley, M.A., Caska, C.M., Hendrickson, B.E., Rourke, M.A., Ho, J., Ali, S., Depression and inflammation in patients with coronary heart disease: findings from the Heart and Soul Study. Biol. Psychiatry 62 (2007), 314–320.
63. de Wit, L., Luppino, F., van Straten, A., Penninx, B., Zitman, F., Cuijpers, P., Depression and obesity: a meta-analysis of community-based studies. Psychiatry Res. 178 (2010), 230–235.